Review
doi: 10.4081/reumatismo.2004.9.
P-31 magnetic resonance spectroscopy. A tool for diagnostic purposes and pathophysiological insights in muscle diseases
Affiliations
- PMID: 15105904
- DOI: 10.4081/reumatismo.2004.9
Item in Clipboard
Review
P-31 magnetic resonance spectroscopy. A tool for diagnostic purposes and pathophysiological insights in muscle diseases
Reumatismo.
2004 Jan-Mar.
Free article
Abstract
31P Magnetic Resonance Spectroscopy (MRS) is a potent tool allowing the investigation of muscle energetics in a noninvasive manner in humans. This review details the contribution of 31P MRS to the diagnosis of metabolic myopathies and provides some clues for the use of this technique in a clinical perspective. Finally, the contribution of 31P MRS to our understanding of the physiopathology of several other diseases is highlighted.
Similar articles
-
Clinical utility of muscle MR spectroscopy.Semin Musculoskelet Radiol. 2000;4(4):481-502. doi: 10.1055/s-2000-13172. Semin Musculoskelet Radiol. 2000. PMID: 11371330 Review.
-
[Non-invasive investigation of muscle function using 31P magnetic resonance spectroscopy and 1H MR imaging].Rev Neurol (Paris). 2006 Apr;162(4):467-84. doi: 10.1016/s0035-3787(06)75038-x. Rev Neurol (Paris). 2006. PMID: 16585908 Review. French.
-
Insights into muscle diseases gained by phosphorus magnetic resonance spectroscopy.Muscle Nerve. 2000 Sep;23(9):1316-34. doi: 10.1002/1097-4598(200009)23:9<1316::aid-mus2>3.0.co;2-i. Muscle Nerve. 2000. PMID: 10951434 Review.
-
[Non invasive investigation of muscle diseases using 31P magnetic resonance spectroscopy: potential in clinical applications].Rev Neurol (Paris). 2002 May;158(5 Pt 1):527-40. Rev Neurol (Paris). 2002. PMID: 12072821 Review. French.
-
MR spectroscopy and imaging in metabolic myopathies.Neurol Clin. 2000 Feb;18(1):35-52. doi: 10.1016/s0733-8619(05)70178-x. Neurol Clin. 2000. PMID: 10658168 Review.
Cited by
-
31P MR spectroscopy and in vitro markers of oxidative capacity in type 2 diabetes patients.MAGMA. 2006 Dec;19(6):321-31. doi: 10.1007/s10334-006-0060-0. Epub 2006 Dec 19. MAGMA. 2006. PMID: 17180611
-
Impaired in vivo mitochondrial function but similar intramyocellular lipid content in patients with type 2 diabetes mellitus and BMI-matched control subjects.Diabetologia. 2007 Jan;50(1):113-20. doi: 10.1007/s00125-006-0475-1. Epub 2006 Nov 9. Diabetologia. 2007. PMID: 17093944
-
Restoration of muscle mitochondrial function and metabolic flexibility in type 2 diabetes by exercise training is paralleled by increased myocellular fat storage and improved insulin sensitivity.Diabetes. 2010 Mar;59(3):572-9. doi: 10.2337/db09-1322. Epub 2009 Dec 22. Diabetes. 2010. PMID: 20028948 Free PMC article. Clinical Trial.
-
MR compatible ergometers for dynamic 31P MRS.J Appl Biomed. 2019 Jun;17(2):91-98. doi: 10.32725/jab.2019.006. Epub 2019 Apr 15. J Appl Biomed. 2019. PMID: 34907736 Review.
-
L-Arginine Affects Aerobic Capacity and Muscle Metabolism in MELAS (Mitochondrial Encephalomyopathy, Lactic Acidosis and Stroke-Like Episodes) Syndrome.PLoS One. 2015 May 20;10(5):e0127066. doi: 10.1371/journal.pone.0127066. eCollection 2015. PLoS One. 2015. PMID: 25993630 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
